John Wiley & Sons, Inc. (NYSE:WLY – Get Free Report)’s stock price gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $47.65, but opened at $44.05. John Wiley & Sons shares last traded at $41.72, with a volume of 36,654 shares changing hands.
The company reported $0.47 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.08). John Wiley & Sons had a negative net margin of 10.69% and a positive return on equity of 18.82%. The firm had revenue of $403.81 million during the quarter, compared to analyst estimates of $387.40 million. During the same quarter in the previous year, the business earned $0.27 EPS. John Wiley & Sons’s revenue for the quarter was down 10.5% on a year-over-year basis.
John Wiley & Sons Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, July 25th. Stockholders of record on Tuesday, July 9th were given a dividend of $0.3525 per share. This represents a $1.41 dividend on an annualized basis and a dividend yield of 3.26%. This is an increase from John Wiley & Sons’s previous quarterly dividend of $0.35. The ex-dividend date was Tuesday, July 9th. John Wiley & Sons’s dividend payout ratio (DPR) is presently -38.74%.
Institutional Trading of John Wiley & Sons
John Wiley & Sons Stock Performance
The company has a quick ratio of 0.49, a current ratio of 0.52 and a debt-to-equity ratio of 1.04. The stock has a fifty day moving average price of $45.81 and a two-hundred day moving average price of $40.24. The company has a market capitalization of $2.35 billion, a price-to-earnings ratio of -11.87 and a beta of 0.86.
John Wiley & Sons Company Profile
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
See Also
- Five stocks we like better than John Wiley & Sons
- Investing in the High PE Growth Stocks
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- About the Markup Calculator
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Market Cap Calculator: How to Calculate Market Cap
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.